Company / Revenue
Ginkgo Bioworks Holdings, Inc. Revenue History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$170.2M
FY2025
5-year range
$170.2M / $477.7M
FY2021-FY2025
Trend
-25.1%
vs FY2024
Sector context
#94 of 153
Health Care
What the data says
At $170M, Ginkgo Bioworks Holdings, Inc.'s revenue ranks #94 of 153 in the Health Care sector. Revenue has declined for 3 consecutive years, from $478M in FY2022 to $170M in FY2025.
Based on SEC 10-K filings.
$170M in FY2025 with a 5-year CAGR of +17.3%.
Declined from $251M to $170M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- -29.1%
- 5-Year CAGR
- +17.3%
- 10-Year CAGR
- -
Sector benchmark
#94 of 153 in Health CareTop 61% of 153This company $170.2M Sector average $4.5B
▼
-96.2% below sector average
Key checks
Key Insights
- Ginkgo Bioworks Holdings, Inc.'s revenue has declined for 3 consecutive years.
- 5-year CAGR of +17.3%, indicating consistent growth.
- In FY2025, revenue decreased 25.1% year-over-year.
- Ranks #94 out of 153 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $170.2M | -25.1% |
| FY2024 | $227.0M | -9.7% |
| FY2023 | $251.5M | -47.4% |
| FY2022 | $477.7M | +52.2% |
| FY2021 | $313.8M | +309.4% |
| FY2020 | $76.7M | +41.5% |
| FY2019 | $54.2M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026